 MOUNTAIN VIEW, Calif., July 23, 2020 GLOBE NEWSWIRE -- IRIDEX Corporation Nasdaq: IRIX today announced the Company will release financial results for the second quarter of 2020 after the close of trading on Thursday, August 6, 2020. The Companys management team will host a corresponding conference call beginning at 2:00 p.m. PT 5:00 p.m. ET.Investors interested in listening to the conference call may do so by dialing 844 707-0665 for domestic callers or 703 326-3030 for international callers, using conference ID: 6486158. A live and archived webcast of the event will be available on the Investors section of the Companys website at: IRIDEX IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companys proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEXs current product line is used for the treatment of glaucoma and diabetic macular edema DME and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the IRIDEX website at Relations Contact: Leigh Salvo 415 937-5404 Contact: Jamie Hall Pascale Communications, LLC. 724 417-0167 